We translate scientific findings into everyday life.
International Cell Research.
CelVio Complex®, the secret ingredient in all spermidineLIFE® products, is used in studies by scientifically recognized research teams worldwide and is the top innovation in cell renewal. Thanks to Novel Food approval and the 100% natural origin of CelVio Complex®, human research can be conducted using our spermidine-rich wheat germ extract. Longevity Labs+ was the first to market spermidine with spermidineLIFE® in 2019 and is therefore the #1 contact when research teams conduct studies with spermidine.
Our Scientific Advisory Board - an international team of experts.
We have challenged some of the best scientists and cell researchers working with spermidine with our vision and are accompanied by an international, renowned advisory board. Their role is to critically review our work and support us with ideas and expertise. Our advisory board members come from various fields of medicine and research. With their experience, they support us in driving innovation.
Prof. Dr. Frank Madeo conducts research in the field of cell biology. His work focuses on cell aging, cell renewal and cell death in order to better understand the how and why of human aging and to find ways and strategies to stay healthy as long as possible.
Katja Simon, Ph.D. conducts research at Oxford University in the area of autophagy in the immune system. With her team, she wants to find out how long-lived immune cells use the process of self-digestion to keep renewing themselves.
Prof. Dr. Stephan Sigrist, together with Prof. Dr. Frank Madeo, studied memory loss in flies to gain insights into age-related memory decline in the human brain. They investigated what influence the purification of clumped proteins in the brain has on the memory performance of flies.
In 2016, our managing directors became aware of the research of Frank Madeo and instinctively recognized the importance of this research. They started to work together with the researchers of the University of Graz on a special extraction process and thus founded the spin off Longevity Labs+.
We have quickly gained attention as a company outside of the University of Graz, and we have welcomed Dr. Hannes Androsch as an investor in our company since 2018.
After extensive testing and studies, the first product, spermidineLIFE® Original 365+ was launched in 2019 and was directly among the sales winners in Austrian pharmacies.
In spring 2020, we founded our U.S. subsidiary, Longevity Labs Inc., to mark a significant success. Amid the challenges of that year, we launched spermidineLIFE® Immunity+ in fall 2020 which specifically supports our immune cells.²
Just six months later, in the spring of 2021, we launched the next innovation: spermidineLIFE® Memory+ for our brain cells.³
In 2022 we wanted more! We increased the dosage of our market-leading product spermidineLIFE® Original 365+ from 1 mg to 2 mg spermidine in order to supply our customers' cells even better.¹ We also launched spermidineLIFE® Boost+, which contains the highest spermidine dosage for long-term use.
In 2023, it was time to increase the dosage of spermidineLIFE® Memory+ and spermidineLIFE® Immunity+ to 2 mg spermidine per daily dose. In the fall we also launched a new, innovative product: nadLIFE® Energy+ with the unique combination of niacin, spermidine and zinc. This not only renews our customers' cells every day¹, but also gives them the energy they need.⁶